Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
NCT ID:
NCT06427850
Eligibility Criteria:
Inclusion Criteria:
* Age 30-80 years old
* Degenerative spine problems including spinal stenosis, disc degeneration, spondylolithesis that indicated for single level MI-TLIF
Exclusion Criteria:
* Revision surgery
* Patients who had high risk of complication from TXA
* History of seizure, PE, DVT, thromboembolic episode
* History of TXA allergy
* Patients who had high risk for bleeding
* U/D : CKD stage more than IIIb (GFR\< 45 ml/min/1.73m2), hepatic disease, bleeding disorder
* On anticoagulation drug or antiplatelet drug in 7 days before surgery
* Abnormal coagulation profile (INR \> 1.5) or CBC (platelet \< 100000)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT06427850
Study Brief:
Protocol Section:
NCT06427850